As of May 25
| +0.42 / +2.70%|
The 8 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 16.50, with a high estimate of 30.00 and a low estimate of 13.00. The median estimate represents a +3.13% increase from the last price of 16.00.
The current consensus among 8 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.